Skip to main content

Publications & Presentations

Publications & Presentations

Analytical Validation of a Clinical Grade Prognostic and Classification Artificial Intelligence Laboratory Test for Men with Prostate Cancer

This is the first study of which we are aware to describe the analytical validation (AV) of clinical grade artificial intelli [...]

Read more

Publications & Presentations

Can AI-Driven Cancer Care Help Improve Mental Well-Being?

AI-enabled predictive and prognostic tests allow clinicians a line of sight.

Read more

Publications & Presentations

ArteraAI Validates its Prognostic Model in Advanced Prostate Cancer

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announces [...]

Read more

Publications & Presentations

AI biomarker predictive of long-term ADT benefit in patients with prostate cancer

Investigators have validated the first AI-derived predictive biomarker of long-term androgen deprivation therapy (ADT) benefi [...]

Read more

Publications & Presentations

The Vital Role of Clinical Validation in the Adoption of AI within Healthcare

The healthcare industry has witnessed a significant surge in interest and opportunity to integrate artificial intelligence (A [...]

Read more

Publications & Presentations

ASCO 2023: Discussant: Hitting the Sweet Spot with Radiation and Androgen Deprivation

Following earlier presentations by Dr. Alberto Bossi (PEACE-1 radiotherapy results), Dr. Andrew Armstrong (ArteraAI long-term [...]

Read more

Publications & Presentations

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer

ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced the pub [...]

Read more

Publications & Presentations

ASCO 2023: Digital Histopathology-Based Multimodal Artificial Intelligence Scores Predict Risk of Progression in a Randomized Phase III Trial in Patients with Nonmetastatic Castration-Resistant Prostate Cancer

Dr. Felix Feng presented on the use of digital histopathology-based multimodal artificial intelligence scores to predict risk [...]

Read more

Publications & Presentations

ASCO 2023: AI-Derived Digital Pathology Biomarker Predicts Benefit of Long-Term ADT with Radiotherapy in Localized High-Risk Prostate Cancer

Dr. Andrew J. Armstrong presented the results of a pooled analysis of multiple phase III NRG/RTOG trials aimed at developing [...]

Read more

1 2 3